Arkolith/Insider Trading/ACXP/Form 4

Scodari Joseph C

DirectorAcurx Pharmaceuticals, Inc. (ACXP) · full profile →Form 4 · filed Jan 8, 2025
Net Buying
Open-Market Buys
$25K
Open-Market Sells
$0
Net Open-Market Flow
$25K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 6, 2025Buy(P)25K$1.02$25K28K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 6, 2025Buy(P)25K—$025K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-002054) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML